Bright Minds Biosciences (DRUG) Selling, General & Administrative (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 647.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -1.52 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Bright Minds Biosciences | 464.72 Mn | 405.19 Mn | - | 545,982.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 545,982.55 |
| Dec 31, 2025 | 252,080.21 |
| Sep 30, 2025 | 192,089.60 |
| Jun 30, 2025 | 119,442.70 |
| Mar 31, 2025 | 192,806.12 |
| Dec 31, 2024 | 55,526.99 |
| Sep 30, 2024 | 35,498.11 |
| Jun 30, 2024 | 59,401.51 |
| Mar 31, 2024 | 41,532.37 |
| Dec 31, 2023 | 50,856.30 |
| Sep 30, 2023 | -34,252.38 |
| Jun 30, 2023 | 90,855.96 |
| Mar 31, 2023 | 103,552.31 |
| Dec 31, 2022 | 46,183.91 |
| Sep 30, 2022 | 78,105.37 |
| Jun 30, 2022 | 71,207.15 |
| Mar 31, 2022 | 58,374.60 |
| Dec 31, 2021 | 167,913.55 |
| Sep 30, 2021 | 72,973.64 |
| Jun 30, 2021 | 43,305.68 |
| Mar 31, 2021 | 19,467.25 |
| Dec 31, 2020 | 21,013.46 |
| Sep 30, 2020 | -6,188.74 |